Health Condition 1: K758- Other specified inflammatory liverdiseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients giving consent and maintaining follow-up. 2 Peri and post-menopausal patients with elevated ALT and AST levels. 3 Peri and post-menopausal patients elevated FSH levels. 4 Peri and post-menopausal patients aged 40 to 60 years.
Exclusion criteria
Exclusion criteria: 1 Patients who do not provide consent or fail to maintain follow-up. 2 Peri and post-menopausal patients with hepatitis B or C. 3 Peri and post-menopausal patients with liver cirrhosis. 4 Patients having known adverse drug reactions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| According to the ALT and AST levels measured Pre and Post MedicationTimepoint: The levels of ALT and AST will be measured the beginning of treatment and at the end of 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| The effectiveness of Carduus Marianus Q Along with individualized homeopathic medicine on increased ALT and AST levels in pre and Post Menopausal Women.Timepoint: 12 Months | — |
Countries
India
Contacts
Dr M P K Homoeopathic Medical College Hospital and Research Centre